KVUE Price Prediction Next Week
Technical Analysis
Recent price action shows KVUE trading in a consolidation pattern between $18-$20. The stock has formed a base after its spin-off from Johnson & Johnson in 2023. Key technical indicators suggest:
- RSI around neutral levels, indicating room for movement in either direction
- Support at $18 level which has held multiple tests
- Resistance at $20 which needs to be cleared for further upside
News Sentiment & Fundamental Drivers
Recent news indicates positive developments:
- Marketing investments in skin health showing results with 2.6% organic growth in Q4
- Management expects growth acceleration in H2 2025
- Current dividend yield of 3.5% adds defensive appeal
Valuation Metrics
The stock screens well on quantitative models:
- Rated 81% by Multi-Factor Investor model
- Strong fundamentals and valuation metrics
- Low volatility characteristics with good momentum
Price Prediction for Next Week
Based on technical setup and recent news flow:
- Support: $18.00
- Resistance: $20.00
- Target: $19.25-19.75
The stock is likely to continue consolidating with an upward bias. Positive fundamental developments and defensive characteristics support accumulation at current levels. Key catalysts include:
- Continued momentum in skin health segment
- Overall brand investment payoff
- Stable consumer health demand
Trading Recommendation: BUY
- Entry around $18.50-18.75
- Stop loss below $18.00
- Take profit at $19.75
The stock offers an attractive risk-reward setup with limited downside given its defensive nature and improving business momentum.
KVUE Similar Chart Price Prediction
The price of KVUE is predicted to go up 7.5%, based on the high correlation periods with SYK. The similarity of these two price pattern on the periods is 97.61%.
KVUE
SYK
Up: 7.5%Similarity: 97.61%
KVUE Revenue Forecast
KVUE EPS Forecast
KVUE FAQs
What is KVUE revenue forecast for next quarter？
What is KVUE eps forecast for next quarter？
KVUE VS S&P500
With autonomy from its former parent, Kenvue can allocate resources to best fit its needs and grow the business.
Macro drivers like an aging population and premiumization of health care will act as tailwinds for all of Kenvue's brands.
Kenvue's continued focus on digital advertising and marketing will keep the company well-positioned to fend off any new competitors in e-commerce.
KVUE Analyst's Forecast
Susan Anderson
Canaccord Genuity
Strong Buy
2025-03-05
Price Target
$24 → $29
Upside
+25.87%
Canaccord raised the firm's price target on Kenvue to $29 from $24 and keeps a Buy rating on the shares. The firm raised its price target due to a strong cold/flu season as the elevated incidence rates for cough/cold/flu-like illnesses could drive an unplanned replenishment opportunity.
Korinne Wolfmeyer
Piper Sandler
Buy
2025-02-24
Price Target
$24 → $27
Upside
+15.88%
Lauren Lieberman
Barclays
Hold
2025-01-17
Price Target
$23 → $21
Downside
-0.47%
